Patangan, Silverio G.

HRN: 28-71-57  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/25/2026
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
03/25/2026
04/01/2026
IV
500mg
Q6
Bacterial Peritonitis
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  Intra-abdominal    Compliance to guidelines: